| Janelle A Shah, PA-C | |
|
2960 Technology Pl Ste 103, Waldorf, MD 20601-4968 | |
| (855) 527-7246 | |
| (866) 229-5063 |
| Full Name | Janelle A Shah |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 8 Years |
| Location | 2960 Technology Pl Ste 103, Waldorf, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114419280 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363AS0400X | Physician Assistant - Surgical | PA60839895 (Washington) | Secondary |
| 363AS0400X | Physician Assistant - Surgical | C0007515 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advanced Pain Management Specialists Llc | 3173513959 | 67 |
| Advanced Pain Management Specialists Llc | 3173513959 | 67 |
News Archive
Limited healthy literacy is a major barrier blocking many people from achieving good cardiovascular health or benefiting from effective treatment for heart attacks, heart failure, strokes and other cardiovascular diseases, according to a scientific statement published in the American Heart Association's journal Circulation.
Angiotech Pharmaceuticals, Inc. today announced that it and U.S. Bank National Association, as successor trustee under the Company's subordinated note indenture, dated as of March 23, 2006, at the direction of a majority of the holders of the Company's 7.75% Senior Subordinated Notes due 2014, have executed a supplement to the Subordinated Note Indenture.
Pacing the two lower chambers of the heart, or bi-ventricular pacing, prevented cardiac enlargement as compared to only pacing the right ventricle in pacemaker patients with normal pumping hearts, according to results presented today from the Pacing to Avoid Cardiac Enlargement (PACE) trial, a clinical study supported by Medtronic, Inc..
A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Janelle A Shah, PA-C 201 Defense Hwy Ste 205, Annapolis, MD 21401-7096 Ph: (855) 527-7246 | Janelle A Shah, PA-C 2960 Technology Pl Ste 103, Waldorf, MD 20601-4968 Ph: (855) 527-7246 |
News Archive
Limited healthy literacy is a major barrier blocking many people from achieving good cardiovascular health or benefiting from effective treatment for heart attacks, heart failure, strokes and other cardiovascular diseases, according to a scientific statement published in the American Heart Association's journal Circulation.
Angiotech Pharmaceuticals, Inc. today announced that it and U.S. Bank National Association, as successor trustee under the Company's subordinated note indenture, dated as of March 23, 2006, at the direction of a majority of the holders of the Company's 7.75% Senior Subordinated Notes due 2014, have executed a supplement to the Subordinated Note Indenture.
Pacing the two lower chambers of the heart, or bi-ventricular pacing, prevented cardiac enlargement as compared to only pacing the right ventricle in pacemaker patients with normal pumping hearts, according to results presented today from the Pacing to Avoid Cardiac Enlargement (PACE) trial, a clinical study supported by Medtronic, Inc..
A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.
› Verified 8 days ago
Mrs. Chinyere Ngozi Eze, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 11750 Business Park Dr, Suite 103, Waldorf, MD 20601 Phone: 240-419-3865 | |
Jennifer Hilfiker, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 7 Post Office Rd Ste C, Waldorf, MD 20602 Phone: 301-645-8322 | |
Kristen Elise Lohr, P.A.C. Physician Assistant Medicare: Medicare Enrolled Practice Location: 12090 Old Line Centre, Waldorf, MD 20602 Phone: 301-843-3888 Fax: 301-870-6838 | |
Lilli Elizabeth Conner, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 12070 Old Line Ctr Ste 303, Waldorf, MD 20602 Phone: 301-645-5100 | |
Ili Wathen, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2855 Crain Hwy, Waldorf, MD 20601 Phone: 240-427-1926 | |
Denise Smith Johnson, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 12101 Old Line Ctr, Waldorf, MD 20602 Phone: 301-843-2223 Fax: 301-705-9720 |